These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 29912609

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Poly(ADP-Ribose) Polymerase-1 (PARP-1) Inhibitors Reduce Reactive Gliosis and Improve Angiostatin Levels in Retina of Diabetic Rats.
    Guzyk MM, Tykhomyrov AA, Nedzvetsky VS, Prischepa IV, Grinenko TV, Yanitska LV, Kuchmerovska TM.
    Neurochem Res; 2016 Oct; 41(10):2526-2537. PubMed ID: 27255598
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Role of poly(ADP-ribose) polymerase activation in the pathogenesis of periodontitis in diabetes.
    Adachi K, Miyajima SI, Nakamura N, Miyabe M, Kobayashi Y, Nishikawa T, Suzuki Y, Kikuchi T, Kobayashi S, Saiki T, Mizutani M, Ohno N, Noguchi T, Mitani A, Matsubara T, Naruse K.
    J Clin Periodontol; 2017 Oct; 44(10):971-980. PubMed ID: 28570002
    [Abstract] [Full Text] [Related]

  • 9. Poly(ADP-Ribose) Polymerase-1 inhibition potentiates cell death and phosphorylation of DNA damage response proteins in oxidative stressed retinal cells.
    Martín-Guerrero SM, Casado P, Muñoz-Gámez JA, Carrasco MC, Navascués J, Cuadros MA, López-Giménez JF, Cutillas PR, Martín-Oliva D.
    Exp Eye Res; 2019 Nov; 188():107790. PubMed ID: 31494107
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of poly(ADP-ribose) polymerase may have preventive potential for varicocoele-associated testicular damage in rats.
    Celik-Ozenci C, Kuscu N, Gungor-Ordueri NE, Tasatargil A, Sahin P, Durmus H.
    Andrology; 2017 Mar; 5(2):362-369. PubMed ID: 27992945
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A comparative study of neuroprotective effect of single and combined blockade of AT1 receptor and PARP-1 in focal cerebral ischaemia in rat.
    Singh N, Sharma G, Singh N, Hanif K.
    Int J Stroke; 2014 Jul; 9(5):560-8. PubMed ID: 23013350
    [Abstract] [Full Text] [Related]

  • 13. PARP-1 inhibition alleviates diabetic cardiac complications in experimental animals.
    Zakaria EM, El-Bassossy HM, El-Maraghy NN, Ahmed AF, Ali AA.
    Eur J Pharmacol; 2016 Nov 15; 791():444-454. PubMed ID: 27612628
    [Abstract] [Full Text] [Related]

  • 14. Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders.
    Henning RJ, Bourgeois M, Harbison RD.
    Cardiovasc Toxicol; 2018 Dec 15; 18(6):493-506. PubMed ID: 29968072
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Curcumin ameliorated diabetic neuropathy partially by inhibition of NADPH oxidase mediating oxidative stress in the spinal cord.
    Zhao WC, Zhang B, Liao MJ, Zhang WX, He WY, Wang HB, Yang CX.
    Neurosci Lett; 2014 Feb 07; 560():81-5. PubMed ID: 24370596
    [Abstract] [Full Text] [Related]

  • 17. PARP inhibition ameliorates nephropathy in an animal model of type 2 diabetes: focus on oxidative stress, inflammation, and fibrosis.
    Zakaria EM, El-Maraghy NN, Ahmed AF, Ali AA, El-Bassossy HM.
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Jun 07; 390(6):621-631. PubMed ID: 28224182
    [Abstract] [Full Text] [Related]

  • 18. Poly (ADP-ribose) polymerase-1: an emerging target in right ventricle dysfunction associated with pulmonary hypertension.
    Kaur G, Singh N, Lingeshwar P, Siddiqui HH, Hanif K.
    Pulm Pharmacol Ther; 2015 Feb 07; 30():66-79. PubMed ID: 25481773
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Nrf2 Activation Is a Potential Therapeutic Approach to Attenuate Diabetic Retinopathy.
    Deliyanti D, Alrashdi SF, Tan SM, Meyer C, Ward KW, de Haan JB, Wilkinson-Berka JL.
    Invest Ophthalmol Vis Sci; 2018 Feb 01; 59(2):815-825. PubMed ID: 29411009
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.